"Producing Orally Bioavailable Biologics" Nick Terrett . 8 May 2013
"Macrocycle Diary's New Entry: Ensemble Deal with Boehringer" Randy Osborne. 2 November 2012
“Excited About Cycling” Chris Cain. 8 September 2012
“Genentech, Ensemble Partner for Macrocycle Drug Discovery ” Nancy Faigen. 8 June 2012
“Assembling Around Ensemblins ” Michael Flanagan. June 2012
“Protein-Protein Interaction Inhibitors get into the Groove” Asher Mullard. March 2012
“Macrocycles by the Trillions” Joanne Kotz. 26 January 2012
Macrocycles: Going Where no Drugs Have Gone Before Mari Serabrov. 2011 November 28
Ensemble Therapeutics Moves Ahead with Mid-Sized Drugs in a Super-Sized Library Luke Timmerman. 2011 July 19
Delivery Of First Macrocyle to Bristol-Myers Squibb Enables Ensemble Therapeutics to Look Ahead Joseph Haas. 2011 April 12
Ensemble hits Macrocycle Milestone Carmen Drahl. 2011 April 12
Making Mid-sized Macrocyclic Molecules, en Masse Deborah Erickson. 2011 March: Vol. 16 No. 3
Company Profile: Chemical Ensemble Sarah Houlton. 2011 March
Ensemble Discovery's CEO, Dr. Mike Taylor, discussing Pfizer alliance on NECN. January 6, 2010
Constraining Molecules in Macrocyclic Rings Could Help Address Challenges in Drug Discovery Andrew Good & Jodi Muckelbauer/BMS. 2009 Sep 7;Volume 87, Number 36 pp. 54-57
Breaking the Rule (of Five) Kevin Davies. 2008 Apr 1
4/1/2013 - Ensemble Therapeutics to Present Data on IL-17A Inhibitors that are Novel, Oral Macrocycles Against Previously Undruggable Target
2/13/2013 - Ensemble Therapeutics Presents Data Demonstrating Unique Properties of Synthetic Macrocycles for Pursuing Challenging Targets
11/12/2012 - Ensemble Therapeutics Presents Oral Efficacy of First-in-Class Small Molecule Targeting IL-17 for Inflammation in Preclinical Studies
11/01/2012 - Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates
10/29/2012 - Ensemble Therapeutics to Present at 2012 ACR Annual Meeting
5/29/2012 - Ensemble Therapeutics and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates
1/5/2012 - Ensemble Therapeutics Advances Macrocycle IL-17 Antagonist Program: Reports First Known Small Molecule Inhibitors of Important Autoimmune Target
1/5/2012 - Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myer Squibb
7/6/2011 - Ensemble Therapeutics Receives Two Notices of Allowance for Fundamental Patents to DNA-Programmed Chemistry Process for Novel Macrocycle Therapeutics
4/12/2011 - Ensemble Therapeutics Achieves Milestone in Bristol-Myers Squibb Collaboration
11/2/2010 - Ensemble Awarded Three Therapeutic Discovery Project Grants Totaling $744,000
9/15/2010 - Ensemble Therapeutics Appoints Ted Hibben as Senior Vice President, Corporate Development
8/23/2010 - Ensemble Therapeutics Presents Data at American Chemical Society National Meeting
6/22/2010 - Ensemble Evolves Name to Ensemble Therapeutics Corporation and Also Announces New Strategic Investor: Kisco Ltd.
1/6/2010 - Ensemble Discovery Initiates Collaboration with Pfizer to Develop Novel Drugs Against Protein-Protein Interaction Targets
4/15/2009 - Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class
11/13/2008 - Ensemble Discovery and Roche Initiate Product Development Program to Advance New Diagnostic Technology to Optimize Cancer Therapy
